Are drug prices really too high, as President Trump implies? Robert Zirkelbach, Executive Vice President of Public Affairs for Pharmaceutical Research and Manufacturers of America (PhRMA), and Steven Pearson, Founder and President of the Institute for Clinical and Economic Review (ICER), join host John Barkett to discuss whether the prices we pay for prescription drugs represent the value those drugs provide and what could be done to possibly lower prescription drug prices on The Business of Health Care.
This Week in Business
Panel Discussion: Are Current Prescription Drug Pricings Fair?
Are drug prices really too high, as President Tru…
November 1, 2017
• 53 min listen
Are drug prices really too high, as President Tru…
Subscribe wherever you listen to your podcasts.
Comments
New This Week
Want More Women Candidates? Ask Employees for More Referrals
A Wharton paper found that increasing referral targets prompted employees to look beyond their first choices, bringing more women into the recruitment pipeline.
Podcast
The AI Boom Is Testing America’s Power Grid
Serguei Netessine, Wharton’s senior vice dean for innovation and global initiatives, examines AI’s growing electricity demand and the infrastructure needed to support it.
The Way of Excellence: Lead for Sustainable Performance
In this Nano Tool for Leaders, author Brad Stulberg explains why you should stop thinking of excellence as a destination and more as a process of growth.
